MedTrace Logo

A Study of Sleeve Gastrectomy Risks and Benefits

NCT06075511 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-01-30

No results posted yet for this study

Summary

This research study is being conducted to collect information to improve the outcomes of patients who have renal failure and are scheduled to have a sleeve gastrectomy.

Conditions

  • Renal Failure

Interventions

DIAGNOSTIC_TEST

6 minutes walk distance

Subjects walk as far as possible for 6 minutes at a self-selected pace, and the total distance walked will be recorded

BEHAVIORAL

Activity Monitor

Subjects will wear an Actigraph on their wrist like a watch for up to 10 days at home to monitor activity.

BEHAVIORAL

Continuous Glucose Monitor

Subjects will collect glucose values in the fluid under their skin for up to 10 days at home.

BEHAVIORAL

Blood Pressure Monitoring

Subjects will monitor their blood pressure at home for 10 consecutive days 3 times a day

DIAGNOSTIC_TEST

Blood Pressure Monitoring

24-hour ambulatory blood pressure monitoring

DIAGNOSTIC_TEST

Body Composition Scan

Measure of body fat percentage, skeletal muscle mass, body water, and visceral fat.

DIAGNOSTIC_TEST

Mixed meal testing

Subjects will consume 6 ml/kg body weight of Boost, up to maximum of 360 ml, within 5 min

DIAGNOSTIC_TEST

Quality of Life

Subject will complete Quality of Life Questionnaire

Sponsors & Collaborators

Principal Investigators

  • Aleksandra Kukla, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2026-03-31
Completion
2026-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06075511 on ClinicalTrials.gov